Blood biomarker panel distinguishes Alzheimer disease from controls in validation study
A single-center cross-validation study found a blood biomarker panel separated Alzheimer disease from healthy controls with near-perfect internal accuracy.
From stroke to neurodegeneration — the science and its clinical impact.
From stroke to neurodegeneration — the science and its clinical impact.